These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
460 related articles for article (PubMed ID: 26311528)
1. Platelet activation is less enhanced in the new balloon expandable Edwards Sapien 3 valve compared to its predecessor model (Edwards Sapien XT). Fateh-Moghadam S; Voesch S; Htun P; Jorbenadze R; Geisler T; Gawaz M; Bocksch W Thromb Haemost; 2016 Jan; 115(1):109-16. PubMed ID: 26311528 [TBL] [Abstract][Full Text] [Related]
2. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement. Bocksch W; Grossmann B; Geisler T; Steeg M; Droppa M; Jorbenadze R; Haap M; Gawaz M; Fateh-Moghadam S Catheter Cardiovasc Interv; 2016 Sep; 88(3):466-75. PubMed ID: 27184353 [TBL] [Abstract][Full Text] [Related]
4. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry. Schymik G; Lefèvre T; Bartorelli AL; Rubino P; Treede H; Walther T; Baumgartner H; Windecker S; Wendler O; Urban P; Mandinov L; Thomas M; Vahanian A JACC Cardiovasc Interv; 2015 Apr; 8(5):657-69. PubMed ID: 25946437 [TBL] [Abstract][Full Text] [Related]
5. Feasibility and safety of transfemoral implantation of Edwards SAPIEN XT prosthesis without balloon valvuloplasty in severe stenosis of native aortic valve. García E; Martín P; Hernández R; Rodríguez V; Fernández A; Gama V; Almería C; Macaya C Catheter Cardiovasc Interv; 2014 Apr; 83(5):791-5. PubMed ID: 24285561 [TBL] [Abstract][Full Text] [Related]
6. Echocardiographic outcomes of self-expandable CoreValve versus balloon-expandable Edwards SAPIEN XT valves: the comparison of two bioprosthesis implanted in a single centre. Kaya D; Tanriverdi Z; Dursun H; Colluoglu T Int J Cardiovasc Imaging; 2016 Sep; 32(9):1371-1378. PubMed ID: 27278270 [TBL] [Abstract][Full Text] [Related]
7. Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement. Wong SC; Pawar S; Minutello RM; Horn EM; Skubas NJ; Devereux RB; Salemi A J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1111-7. PubMed ID: 26277463 [TBL] [Abstract][Full Text] [Related]
8. Clinical impact of aortic regurgitation after transcatheter aortic valve replacement: insights into the degree and acuteness of presentation. Jerez-Valero M; Urena M; Webb JG; Tamburino C; Munoz-Garcia AJ; Cheema A; Dager AE; Serra V; Amat-Santos IJ; Barbanti M; Immè S; Alonso Briales JH; Al Lawati H; Benitez LM; Cucalon AM; Garcia del Blanco B; Revilla A; Dumont E; Barbosa Ribeiro H; Nombela-Franco L; Bergeron S; Pibarot P; Rodés-Cabau J JACC Cardiovasc Interv; 2014 Sep; 7(9):1022-32. PubMed ID: 25234675 [TBL] [Abstract][Full Text] [Related]
9. Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: management of paravalvular regurgitation after TAVR. Martinez CA; Singh V; O'Neill BP; Alfonso CE; Bilsker MS; Martinez Clark P; Williams D; Cohen MG; Heldman AW; O'Neill WW Catheter Cardiovasc Interv; 2013 Aug; 82(2):300-11. PubMed ID: 23580318 [TBL] [Abstract][Full Text] [Related]